1,2-distearoyllecithin has been researched along with Carcinoma, Anaplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwatsuru, M; Koyama, M; Maruyama, K; Suginaka, A; Takahashi, N; Unezaki, S; Yuda, T | 1 |
Ishida, O; Iwatsuru, M; Maruyama, K; Takahashi, N; Unezaki, S | 1 |
2 other study(ies) available for 1,2-distearoyllecithin and Carcinoma, Anaplastic
Article | Year |
---|---|
Enhanced delivery and antitumor activity of doxorubicin using long-circulating thermosensitive liposomes containing amphipathic polyethylene glycol in combination with local hyperthermia.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antineoplastic Agents; Carcinoma; Colonic Neoplasms; Doxorubicin; Hydrogen-Ion Concentration; Hyperthermia, Induced; Liposomes; Male; Mice; Mice, Inbred BALB C; Molecular Weight; Phosphatidylcholines; Polyethylene Glycols; Tissue Distribution | 1994 |
Enhanced tumor targeting of doxorubicin by ganglioside GM1-bearing long-circulating liposomes.
Topics: Animals; Carcinoma; Cholesterol; Colonic Neoplasms; Doxorubicin; Drug Carriers; Drug Compounding; G(M1) Ganglioside; Hydrogen-Ion Concentration; Liposomes; Male; Mice; Mice, Inbred BALB C; Particle Size; Phosphatidylcholines; Tissue Distribution | 1993 |